Top 50 Life Science Startup Investors in Spain (May 2026)
For AI agents: Short investor table (Markdown), Detailed investor list (Markdown)
| Investor | Relevant Deals | Geography | Stage | Focus | Round Size |
|---|---|---|---|---|---|
|
Capital Cell
VC Fund
|
6 | Spain, United States, United Kingdom | Equity Crowdfunding, Seed | Health Care, Biotechnology, Medical | $134k–$1.9M |
|
Centre for the Development of Industrial Technology (CDTI)
VC Fund
|
5 | Spain, United States, France | Seed, Grant | Biotechnology, Health Care, Software | $123k–$4.4M |
|
Bullnet Capital
VC Fund
|
4 | Spain, United States, Mexico | Series A, Seed | Software, Information Technology, Enterprise Software | $3.2M–$3.2M |
|
Asabys Partners
VC Fund
|
4 | Spain, Belgium, Germany | Series A, Seed, Series B | Biotechnology, Health Care, Medical Device | $1.2M–$41M |
|
ENISA
VC Fund
|
3 | Spain, United States, France | Seed, Debt Financing, Pre-Seed | Software, Health Care, Information Technology | $62k–$1.3M |
|
Inveready
VC Fund
|
3 | Spain, United States, United Kingdom | Seed, Series A | Software, Biotechnology, Information Technology | $429k–$11M |
|
Alta Life Sciences
VC Fund
|
2 | Spain, United States | Series A, Seed | Biotechnology, Health Care, Medical Device | $3M–$32M |
|
Demium Capital
VC Fund
|
2 | Spain, Portugal, Poland | Pre-Seed, Seed, Series A | Software, Health Care, Information Technology | $27k–$1.2M |
|
Amino Collective
VC Fund
|
2 | Germany, United States, United Kingdom | Seed, Series A, Pre-Seed | Health Care, Biotechnology, Software | $2.9M–$6M |
|
Ysios Capital
VC Fund
|
2 | Spain, United States, Switzerland | Series A, Series B, Series C | Biotechnology, Health Care, Medical | $2.1M–$48M |
|
Charme Capital Partners
VC Fund
|
2 | Spain | Series A | Genetics, Life Science, Biotechnology | $5.4M–$20M |
|
Caixa Capital Risc
VC Fund
|
2 | Spain, United States, United Kingdom | Seed, Series A | Software, Biotechnology, E-Commerce | $246k–$17M |
|
Monte Carlo Capital
VC Fund
|
2 | United States, United Kingdom, Spain | Seed, Series A | Medical Device, Artificial Intelligence, Medical | $165k–$9.3M |
|
BoxOne Ventures
VC Fund
|
2 | Canada, United States, Spain | Seed, Series A, Pre-Seed | Biotechnology, Health Care, Software | $91k–$3.1M |
|
Xesgalicia
VC Fund
|
2 | Spain, Portugal | Seed, Pre-Seed | Software, Biotechnology, B2B | $504k–$2M |
|
Talis Capital
VC Fund
|
2 | United Kingdom, United States, Germany | Series A, Seed, Series B | Software, Information Technology, E-Commerce | $1M–$28M |
|
Invivo Capital Partners
VC Fund
|
2 | Spain, France | Seed | Biotechnology, Health Care, Life Science | $1.6M–$13M |
|
Speedinvest
VC Fund
|
2 | Germany, United Kingdom, Austria | Seed, Series A, Pre-Seed | Software, FinTech, Financial Services | $396k–$50M |
|
Amadeus Capital Partners
VC Fund
|
2 | United Kingdom, United States, Spain | Seed, Series B, Series A | Software, Artificial Intelligence, Machine Learning | $800k–$43M |
|
Inaki Berenguer
Angel
|
1 | Spain, United States, United Kingdom | Seed, Angel, Pre-Seed | E-Commerce, FinTech, Enterprise Software | $215k–$9M |
|
Addition
VC Fund
|
1 | United States, India, Brazil | Series A, Series B, Series C | Software, FinTech, Artificial Intelligence | $12M–$300M |
|
David Brandes
Angel
|
1 | Spain | Seed | Wellness, Life Science, Biotechnology | |
|
Grow Venture Partners
VC Fund
|
1 | Spain | Pre-Seed | Biotechnology, Robotics, Biopharma | $134k–$375k |
|
Fides Capital
VC Fund
|
1 | Spain | Seed, Pre-Seed, Series A | Telecommunications, Software, Automotive | |
|
Inveniam
VC Fund
|
1 | Spain | Seed | Biopharma, Health Care, Life Science | |
|
Catalan Institution for Research and Advanced Studies
VC Fund
|
1 | Spain | Seed | Life Science, Biotechnology | |
|
Mariliis Holm
Angel
|
1 | Spain, Iceland | Pre-Seed | Seafood, Wellness, Life Science | $300k–$500k |
|
Fund+
VC Fund
|
1 | Belgium, United States, Spain | Series A, Series B, Series C | Biotechnology, Health Care, Therapeutics | $9.6M–$125M |
|
Arnaldo Marziali
Angel
|
1 | Spain | Pre-Seed | Big Data, Software, Life Science | |
|
Debiopharm Innovation Fund
VC Fund
|
1 | Switzerland, United States, France | Series A, Series B, Series C | Health Care, Biotechnology, Medical Device | $3.4M–$25M |
|
CDTI
VC Fund
|
1 | Spain, United States, Mexico | Seed, Debt Financing | Software, Information Technology, Health Care | $268k–$2.6M |
|
Banc Sabadell and the Institut Català de Finances (ICF)
VC Fund
|
1 | Spain | Pre-Seed, Series A, Debt Financing | Wellness, Health Care, Medical Device | |
|
Arturo Elizondo
Angel
|
1 | Spain, Switzerland | Seed, Pre-Seed | Wellness, Life Science, Biotechnology | |
|
Sofinnova Partners
VC Fund
|
1 | France, United States, United Kingdom | Series A, Series B, Series C | Biotechnology, Health Care, Medical | $4.4M–$57M |
|
Ezten Venture Capital Fund
VC Fund
|
1 | Spain | Seed | Software, Automotive, Clean Energy | |
|
Global health sciences venture fund
VC Fund
|
1 | United States, Canada, Spain | Series A, Series C, Series B | Biotechnology, Health Care, Therapeutics | |
|
Josep Carreras Leukaemia Research Institute
VC Fund
|
1 | Spain | Seed | Life Science, Biotechnology | |
|
Alantra
VC Fund
|
1 | Spain, France, Sweden | Private Equity, Debt Financing, Series B | Financial Services, Manufacturing, Information Technology | $7.5M–$39M |
|
Alma Mundi Ventures
VC Fund
|
1 | Spain, United States, United Kingdom | Series A, Seed | Software, InsurTech, Insurance | $1M–$30M |
|
Grupo Ferrer Internacional
VC Fund
|
1 | Spain | Series A | Biotechnology, Wellness, Biopharma | |
|
Milad Alucozai
Angel
|
1 | United States, Canada, United Kingdom | Seed, Series A, Pre-Seed | Biotechnology, Health Care, Medical | $91k–$60M |
|
Innova-Tech Consulting
VC Fund
|
1 | Canada, Spain | Series A, Seed, Series B | Solar, Energy, Medical | $1.8M–$16M |
|
Clave Mayor
VC Fund
|
1 | Spain, Germany, United States | Seed, Series A | Software, Biotechnology, Medical | $256k–$8.9M |
|
CRB Inverbío
VC Fund
|
1 | Spain, Mexico | Series A, Seed | Medical, Health Care, Biotechnology | $2.1M–$8.9M |
|
Nina Capital
VC Fund
|
1 | United States, United Kingdom, Austria | Seed, Pre-Seed, Series A | Health Care, Artificial Intelligence, Medical | $573k–$21M |
|
Stemar Capital
VC Fund
|
1 | Spain | Series A | Genetics, Life Science, Biotechnology | |
|
mVenturesBCN
VC Fund
|
1 | Spain | Seed | Biopharma, Health Care, Life Science | |
|
Kurma Partners
VC Fund
|
1 | France, Spain, Switzerland | Series A, Seed, Series B | Health Care, Biotechnology, Medical | $2.1M–$80M |
|
Pontifax
VC Fund
|
1 | United States, Israel, France | Series A, Series B, Series C | Biotechnology, Health Care, Therapeutics | $3.8M–$100M |
|
Arman Anatürk
Angel
|
1 | Spain, Israel, Germany | Seed, Pre-Seed | Biotechnology, Food and Beverage, Wellness | $1.9M–$8.4M |
| Access all 85 investors in Spain Life Science startups. | |||||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Investor list
Capital Cell is a pan-European crowdinvesting platform for Biotech & Life Sciences companies. Mixing VC, business angels, accredited investors and the power of the Crowd, the company is building a global meeting point for companies and researchers working, fostering and financing tomorrow’s medical science.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical
- Stage:Equity Crowdfunding, Seed
- Geography: Spain, United States, United Kingdom
Investor stats
- Total investments: 42
- Round size: Seed $375k–$1.9M; Equity Crowdfunding $134k–$1.2M
- Lead/follow: 24% lead, 76% follow
Portfolio highlights
- Exheus — Exheus tells everything that you need to know to take maximum care of yourself and avoid risks to your health, exheus is much more than a DNA test that only indicates which genes you have.
- MediQuo — MediQuo is a hospital in your pocket, connecting patients and professionals for any health interaction. Healthcare today has 75% of unnecessary medical visits that could be taken in the distance, and the vast majority of health professionals are using messaging platforms such as WhatsApp to communicate with patients or other health professionals.MediQuo is a chat-based app specialised in health, GDPR and health data compliant, giving professionals time control, incorporating patient medical history and phone privacy. Allowing also video and audio communication. It is a place for discussion, appointments or medical consultation with your doctor or any new health professional. Also includes immediate 24/7 medical response and a network, for health information and professional discovery. We have done already 1M consultations and got 600k app downloads. Our Google Play Ratings are 4,6 (with 6k reviews). We are amongst the top health apps in Spain and Latam.
- Oncostellae — Oncostellae is a biotechnology startup developing small-molecule drugs with innovative scaffolds (NCEs) that modulate clinically validated therapeutic targets in oncology and inflammatory/autoimmune diseases.
The Center for Industrial Technological Development (CDTI) is a public corporation under the Ministry of Economy and Competitiveness, which promotes innovation and technological development of Spanish companies. Is the entity which channels requests for funding and support to projects I + D + i of Spanish companies in the national andinternational levels. The CDTI has a staff of more than 300 people formed three quarters of engineers and graduates. Although the bulk of the infrastructure of the CDTI is located in Madrid, the Centre offers Spanish companies a strategic network of offices and representatives abroad (Japan -SBTO (Spain Business and Technology Office) - Belgium -SOST (Spain Office of Science and Technology) and Permanent Secretariat Eureka-, Brazil -FINEP (Financier of Studies and Projects) -, Korea, Chile, Morocco, China, India, Mexico and USA) to support them in their technological activities of type int .
Show more...Investment focus
- Industry: Biotechnology, Health Care, Software
- Stage:Seed, Grant
- Geography: Spain, United States, France
Investor stats
- Total investments: 106
- Round size: Seed $536k–$4.4M; Grant $123k–$841k
- Lead/follow: 35% lead, 65% follow
Portfolio highlights
- inari — INARI provides blockchain, machine learning and artificial intelligence technologies for the Insurance industry
- Candam — Candam is a technology company that provides innovative technological solutions for rewarding and refund of disposable waste.
- wooptix — Wooptix is a developer of light field and wavefront phase imaging platform designed to acquire all information about the light using
Independent Venture Capital Firm specialized in high technology Spanish start-ups. Helping tech entrepreneurs during the early stages of their company to build successful businesses
Show more...Investment focus
- Industry: Software, Information Technology, Enterprise Software
- Stage:Series A, Seed
- Geography: Spain, United States, Mexico
Investor stats
- Total investments: 36
- Round size: Series A $3.2M–$3.2M
- Lead/follow: 39% lead, 61% follow
- Last fund: May invest from a new fund soon — raised $45M in 2015
Portfolio highlights
- Quside — Our QRNGs let innovators build advanced solutions for cybersecurity and computation.
- wooptix — Wooptix is a developer of light field and wavefront phase imaging platform designed to acquire all information about the light using
- Deep Detection — Multispectral x-ray camera for food & beverage inspection
Asabys Partners is a venture capital firm that invests across the board in human healthcare. The company is active in the health-tech and biopharma industries and aims to invest in Spain and abroad in innovative and transformative technologies. Asabys Partners are motivated by the idea of pushing the boundaries of science and medicine. This is donethrough the sourcing and financing of the most disruptive technologies, and through the collaboration with the best internal and external talents of our industry.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical Device
- Stage:Series A, Seed, Series B
- Geography: Spain, Belgium, Germany
Investor stats
- Total investments: 21
- Round size: Seed $1.2M–$13M; Series A $4.4M–$32M; Series B $18M–$41M
- Lead/follow: 55% lead, 45% follow
- Last fund: Likely still investing — raised $107M in 2022
Portfolio highlights
- DeepUll — DeepUll is a biotech company that focuses its activity on the development of a new diagnostic system for early-stage sepsis condition. DeepUll’s proposal is based on quickly identifying the pathogens and offering the antibiogram within a few hours on the one hand, and on using the data and learning about the patient’s immunological and functionalstatus on the other. The system allows doctors to predict the future appearance and evolution of sepsis within a short period of time and thus provide a suitable clinical response even before the symptoms arise.
- Orikine Bio — Orikine Bio is a pioneer biotech company in the field of tailored cytokines with unmatched biological properties for the treatment of immune-mediated disorders.
- Nuage Therapeutics — Nuage Therapeutics is a pharmaceutical company which utilizes chemical biology and biomolecular condensation to develop selective drugs that target proteins with disordered regions for challenging indications to improve patient’s life. The focus of the medication is to enhance selective inhibitors of intrinsically disordered proteins involved inchallenging indications in order to meet unmet medical needs.
ENISA is a public company under the Ministry of Industry, Energy and Tourism, through the Directorate General of Industry and Small and medium-sized enterprises which, since 1982, actively participates in the financing of viable and innovative business projects.
Show more...Investment focus
- Industry: Software, Health Care, Information Technology
- Stage:Seed, Debt Financing, Pre-Seed
- Geography: Spain, United States, France
Investor stats
- Total investments: 115
- Round size: Seed $64k–$1.3M; Pre-Seed $161k–$536k; Debt Financing $62k–$429k
- Lead/follow: 34% lead, 66% follow
Portfolio highlights
- aunoa — We are an Artificial Intelligence Software company focused on providing automation tools to improve customer experience and support
- Yuvod — Create your own end to end OTT and/or IPTV platform so you can focus on acquiring customers.
- Bemyvega — Bemyvega is a platform to broadcast and stream live classes.
Inveready is a leading alternative asset manager in Spain - investing in early-stage VC, growth VC, venture debt, strategic equity in listed companies, infrastructure and private equity - providing financing solutions to companies throughout their life-cycle. Founded in 2008, Inveready counts on 177 active companies, 61 exits and more than €1bnof assets under management. Some of our portfolio companies have been acquired by multinationals such as Intel, Symantec, IBM, and Facebook, whilst others are listed in public markets such as NASDAQ, the Spanish BME Growth, AIM London, and Euronext Growth. (visit www.inveready.com for more information)
Show more...Investment focus
- Industry: Software, Biotechnology, Information Technology
- Stage:Seed, Series A
- Geography: Spain, United States, United Kingdom
Investor stats
- Total investments: 108
- Round size: Seed $429k–$5.4M; Series A $1.6M–$11M
- Lead/follow: 52% lead, 48% follow
- Last fund: Likely still investing — raised $54M in 2022
Portfolio highlights
- MedUX — MedUX is the leading Customer Experience and Network monitoring solution for telecommunication services, governments, and OTT providers by using AI Powered Real-Time Applied Analytics
- Sia — Sia is an AI platform that utilizes your proprietary datasets to train ChatGPT-like models, creating intelligent applications capable of sophisticated interactions within your business ecosystem.
- All Structured Notes — All Structured Notes is the fintech specialized in the democratization of structured notes.
Alta Life Sciences is a leading multistage venture capital investment firm. Alta LS will invest in companies at all stages of development: from seed financing through commercial growth. Alta LS invests in all areas of life sciences including biotechnology, medical devices, diagnostics, genomics and digital health.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical Device
- Stage:Series A, Seed
- Geography: Spain, United States
Investor stats
- Total investments: 14
- Round size: Series A $3M–$32M
- Lead/follow: 50% lead, 50% follow
Portfolio highlights
- Peptomyc — Peptomyc is a company focused on the development of a new generation of cell-penetrating peptides (CPPs) targeting the Myc oncoprotein for cancer treatment. The company was founded in December 2014 and it is based on Dr. Soucek’s scientific research in Omomyc (the best direct Myc inhibitor known to date) over the last twenty years.Currently,cancer incidence in the world exceeds 14 million cases per year and results in 8 million deaths annually. Moreover, such numbers are forecast to rise by 75% over the next 20 years (World Cancer Report. International Agency for Research on Cancer 2014). At the moment, standard therapies include surgery, radiotherapy, chemotherapy, and, in a restricted subset of cancers, precision medicine. Unfortunately, very often these therapies fail, due to the development of resistance.Peptomyc has adopted a different strategy based on the inhibition of the oncoprotein Myc, which is found deregulated in the majority of human cancers. Myc holds a non-redundant function in cancer around which tumors cannot evolve, hence targeting Myc is the most promising therapeutic opportunity to date. Although Myc plays a central role in cancer there is currently no Myc inhibitor in the market.
- Binx Health — Binx Health is creating new categories of healthcare solutions that deliver on-demand testing to people where they need it most. With its proprietary, desktop, PCR-based point-of-care testing platforms and consumer mobile offerings, the company is redefining “convenient care” for the modern consumer
- Mediktor — Mediktor is an interactive tool that can analyse users' symptoms and evaluate their state of health. It also allows them to chat with a doctor in real time.
Demium is a talent investment company founded in Spain in 2013 with the aim of supporting the best professionals and helping them to carry out successful projects, always with an eminently digital and technological component. In November 2020, it's asset management company, Demium Capital, started operating with a first €50M fund to invest inmore than 75 early-stage startups per year (pre-seed/seed), becoming the most active venture capital fund in Spain. Startups such as Hannun, Voicemod, Swipcar, Citibox, Singularu or Landbot, among others have been created in the incubator. The company is present in five countries: Spain, Portugal, Poland, Ukraine and Czech Republic
Show more...Investment focus
- Industry: Software, Health Care, Information Technology
- Stage:Pre-Seed, Seed, Series A
- Geography: Spain, Portugal, Poland
Investor stats
- Total investments: 58
- Round size: Seed $27k–$1.2M; Pre-Seed $107k–$193k
- Lead/follow: 66% lead, 34% follow
- Last fund: May invest from a new fund soon — raised $54M in 2020
Portfolio highlights
- Coolx — Coolx has a mission to bring technology to the service of forests. Through satellite technology and AI we help environmental consultancies, engineers and forestry managers to optimize the analysis, management and forest conservation.
- Tribboo — Project management platform for construction SMEs
- Nuwe — Nuwe is a startup disrupting how tech professionals get hired and improve their skills, while at the same time it changes the way companies do people management and recruitment. To achieve that,we have developed a gamified platform which allows users to take challenges, participate in projects and contribute to Nuwe’s community sharing knowledgeand helping other users out. All of this contributes to their path to getting a job and their professional self-development.Companies can ask for personalized challenges, getting access to a database of validated users. For companies, wanting to participate in Nuwe’s selection processes not only get a database of validated users, but they generate a huge impact within tech communities which helps them gain a better reputation and have access to more qualified talent in the future. Moreover, companies can also ask for internal employee analytics which will help them optimize their overall performance.
Amino Collective is an investment firm. They enable entrepreneurs and scientists to establish businesses that generate a better future for all species on Earth. The firm intends to invest in the sectors of biology, biotech, health tech, science, digital health, life science, and synthetic biology.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Software
- Stage:Seed, Series A, Pre-Seed
- Geography: Germany, United States, United Kingdom
Investor stats
- Total investments: 24
- Round size: Seed $2.9M–$6M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Lindus Health — Lindus Health. From recruitment to delivery, we accelerate clinical trials. Our mission is to make health research accessible for everyone, everywhere.
- Enveda Biosciences — Enveda Biosciences is a biotechnology company building new medicines from plants. It harnesses the complexity of the natural world to tackle today’s biggest healthcare challenges. With the help of the advancements in knowledge graphs, machine learning, and metabolomics, they discover the next generation of small molecules. Its technologiessystematize the discovery of small molecules and novel targets for complex diseases. By probing novel chemical space and mechanisms of action, they are breaking the status quo for challenging diseases with a need for effective treatments, such as fibrosis or neurodegeneration.Enveda, launched in 2019, is based in San Francisco, California.
- Sensible Biotechnologies — Engineering cells to make better mRNA.
Leading #lifesciences #venturecapital firm financing highly #innovative #biotechnology companies #worlwide.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series A, Series B, Series C
- Geography: Spain, United States, Switzerland
Investor stats
- Total investments: 65
- Round size: Series A $2.1M–$40M; Series B $17M–$37M; Series C $27M–$48M
- Lead/follow: 35% lead, 65% follow
- Last fund: May invest from a new fund soon — last raise in 2020
Portfolio highlights
- VarmX — VarmX is a pharmaceutical spin-off from the Leiden University Medical Center. The mission of VarmX is to develop and manufacture therapeutic proteins to instantaneously restore blood clotting in bleeding patients. The lead product in the pipeline of VarmX is PseudoXa. PseudoXa is a modified recombinant human coagulation factor X which is capable ofimmediately restoring blood clotting in the presence of direct factor Xa anticoagulants (DOACS) such as rivaroxaban, apixaban, and edoxaban.These factor Xa coagulants are taken by millions of patients world-wide for the prevention and treatment of thrombosis and stroke, but as a side effect severe bleeding often occurs. PseudoXa is capable of stopping and preventing such bleedings thus making the usage of DOACS much safer.
- Xeltis — Xeltis is pioneering a restorative approach in cardiovascular therapy.
- ADCendo — ADCendo ApS is a biotech company dedicated to developing new types of anti-cancer drugs. We focus on antibody-drug conjugates (ADCs) directed at novel targets, that have been found to be overexpressed by several cancer forms, that are all characterized by a significant unmet need for novel treatment.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Charme Capital Partners is a European mid-market private equity fund, supporting management teams and shareholders to achieve transformational change, growth and internationalisationFrom our offices in Milan, London and Madrid we invest in businesses across Europe with an enterprise value of €100m to €500mContinuous interaction with ourinvestor base is key in sourcing new opportunities, testing investment theses and growing portfolio companies
Show more...Investment focus
- Industry: Genetics, Life Science, Biotechnology
- Stage:Series A
- Geography: Spain
Investor stats
- Total investments: 2
- Round size: Series A $5.4M–$20M
- Lead/follow: 100% lead, 0% follow
Portfolio highlights
- Veritas Intercontinental — Our test based on whole exome and genome sequencing provides the interpretation of extensive genetic information that can be further analyzed in the future.
Caixa Capital Risc (CCR) is the VC arm of CriteriaCaixa which invests in innovative companies in their start-up and growth stages. The company has three specialised teams in the areas of Information Technology, Life Sciences, and Industrial technologies. Caixa Capital Risc currently manages more than €300m through 11 specialised vehicles.
Show more...Investment focus
- Industry: Software, Biotechnology, E-Commerce
- Stage:Seed, Series A
- Geography: Spain, United States, United Kingdom
Investor stats
- Total investments: 135
- Round size: Seed $246k–$3.2M; Series A $1.8M–$17M
- Lead/follow: 42% lead, 58% follow
- Last fund: Likely still investing — fund raised in 2021
Portfolio highlights
- inari — INARI provides blockchain, machine learning and artificial intelligence technologies for the Insurance industry
- AbolerIS Pharma — AbolerIS Pharma aims to develop novel and unique therapeutic approaches to induce immune tolerance.
- Mobile Media Content - TICKETING3D — Mobile Media Content, a Barcelona, Spain-based provider of virtual visualization technologies, raised €400k in seed funding.Founded in May 2012 by Michele Marino, CEO and Francis Casado, Head of Business Development, Mobile Media Content provides TICKETING3D, a SaaS 3D seating chart of a venue, which allows the final user to check the view fromhis seat before purchasing a ticket. It also Tranfer3D, which lets any club or sports organization to move supporters or fans from one location to another, and Match3D, a 2nd screening tool that allows following matches in real time.The company currently employs 20 people
Monte Carlo Capital was founded in 2009 by former investment banker Ian Sosso, winner of the 2019 “Best European Early Stage Investor” award from EBAN, the Brussels-based European trade association for business angels representing the 30,000 European angel community with a presence in 50 countries. Monte Carlo Capital combines the best featuresof business angels and venture capital. We invest via fund and via SPVs. We have been the Lead in many of our investments and are increasing our Co-Investments with some of the world’s leading VCs. Typical investments start at pre-seed/seed and we regularly follow on to Series A & Series B rounds. Monte Carlo Capital invests across sectors, including Saas, Fintech, DeepTech and Health Care, in the US, Europe and the UK.Our solo managing partner was a former investment banker, spending most of his career in Asia and the UK. He retired about 15 years ago, and set up his own angel group. After being quite successful, he decided to launch the fund (January this year).
Show more...Investment focus
- Industry: Medical Device, Artificial Intelligence, Medical
- Stage:Seed, Series A
- Geography: United States, United Kingdom, Spain
Investor stats
- Total investments: 42
- Round size: Seed $165k–$9.3M; Series A $1.3M–$8.9M
- Lead/follow: 52% lead, 48% follow
Portfolio highlights
- HomeOptions — Home ownership redefined - We pay homeowners to be their future real estate broker.
- Auriga Space — Next-generation space launch company providing frequent, sustainable and affordable transport to low Earth orbit
- Immersive Fox — Immersive Fox develops a text-to-video B2B service to generate video content for companies remotely. It also creates AI-generated microlearning videos from any text for learning management systems and corporate communication.
BoxOne Ventures is a privately held investment firm that focuses on early-stage companies across the most impactful, interesting and fast-changing sectors.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Software
- Stage:Seed, Series A, Pre-Seed
- Geography: Canada, United States, Spain
Investor stats
- Total investments: 39
- Round size: Seed $91k–$3.1M
- Lead/follow: 15% lead, 85% follow
Portfolio highlights
- Dispersa — Harnessing the power of microbe-derived natural solutions to decarbonize the chemicals industry.
- Nimble Science — small intestine sampling technology - Nimble Science
- Vivid Machines — Digitizing permanent crop production | Vivid Machines | Ontario
XesGalicia is a Galician Venture Capital Management firm. It finances company development through the temporary acquisition of minority shares of the capital of unquoted companies.
Show more...Investment focus
- Industry: Software, Biotechnology, B2B
- Stage:Seed, Pre-Seed
- Geography: Spain, Portugal
Investor stats
- Total investments: 24
- Round size: Seed $504k–$2M
- Lead/follow: 21% lead, 79% follow
Portfolio highlights
- Envita — Envita is a social innovation start-up for the development of innovative digital solutions for organizations.
- Libera Bio — Libera Bio is a biopharmaceutical company devoted to the development of a new class of therapeutics to address unmet medical needs in cancer
- Oncostellae — Oncostellae is a biotechnology startup developing small-molecule drugs with innovative scaffolds (NCEs) that modulate clinically validated therapeutic targets in oncology and inflammatory/autoimmune diseases.
We back founders who see the future differently.
Show more...Investment focus
- Industry: Software, Information Technology, E-Commerce
- Stage:Series A, Seed, Series B
- Geography: United Kingdom, United States, Germany
Investor stats
- Total investments: 78
- Round size: Seed $1M–$15M; Series A $2.5M–$18M; Series B $7.7M–$28M
- Lead/follow: 54% lead, 46% follow
- Last fund: May invest from a new fund soon — raised $100M in 2019
Portfolio highlights
- Acin — The Acin data Network and Diagnostics digitize and assure operational risk controls in a connected data Network across the industry.
- Laced — Discover the latest sneaker releases with Laced. The UK and Europe's authentic sneaker marketplace, discover coveted styles from Nike, Air Jordan, Yeezy, New Balance and more. Buy and sell now with Laced.
- Rubi Laboratories — Rubi Laboratories turns carbon emissions into carbon-negative textiles for the fashion industry, with a proprietary synthetic biology technology.
Invivo is focused on investing in early-stage companies in Healthcare sector: biotech, medical devices and e-Health.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Life Science
- Stage:Seed
- Geography: Spain, France
Investor stats
- Total investments: 11
- Round size: Seed $1.6M–$13M
- Lead/follow: 64% lead, 36% follow
- Last fund: May invest from a new fund soon — raised $44M in 2019
Portfolio highlights
- Integra Therapeutics — Integra Therapeutics is a developer of next generation of gene editing tools to cure diseases.
- Telomere Therapeutics — Telomere Therapeutics is a University of Barcelona spinoff developing telomerase gene therapy to treat pulmonary fibrosis
- Corteria Pharmaceuticals — Corteria Pharmaceuticals develops first-in-class drugs in heart failure subpopulations, focused on the development of transformative therapies for the treatment of worsening and acute decompensated heart failure.
Speedinvest is one of Europe’s most active early-stage investors, with more than €1bn AUM, 40 investors, and offices in Berlin, London, Munich, Paris, Vienna and San Francisco. Your success is our priority, so we don’t just send some money and "check in" at board meetings. Our mission is to empower you with game-changing support throughevery stage of your journey. Our focused investment teams know your industry inside and out. Their Deep Tech, Fintech, Industrial Tech, Network Effects, Digital Health and Subscriptions experience, know-how and deep networks are yours from day one. You also have full access to our in-house Platform+ team of operational experts who can provide tailored growth marketing, people (HR), US business development, and networking support throughout every stage of your journey.
Show more...Investment focus
- Industry: Software, FinTech, Financial Services
- Stage:Seed, Series A, Pre-Seed
- Geography: Germany, United Kingdom, Austria
Investor stats
- Total investments: 390
- Round size: Seed $536k–$6.5M; Pre-Seed $396k–$1.9M; Series A $1.4M–$50M
- Lead/follow: 40% lead, 60% follow
- Last fund: Likely still investing — fund raised in 2022
Portfolio highlights
- autone — Autone is a SaaS operational platform enabling retail & CPG businesses to make optimal decisions easily and quickly
- Genie — Genie is a productive web development framework in Julia. Build web applications, UIs, backends, integrate with databases, set up web services and APIs.
- Purpose Green — Purpose Green operates as a climatetech company.
Amadeus Capital Partners, Venture Capital For Technology Companies. We Back Entreprenuers To Win. Contact Our Experienced Team Of Investors Today
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Machine Learning
- Stage:Seed, Series B, Series A
- Geography: United Kingdom, United States, Spain
Investor stats
- Total investments: 197
- Round size: Seed $800k–$7.5M; Series A $2M–$25M; Series B $6M–$43M
- Lead/follow: 27% lead, 73% follow
- Last fund: Likely still investing — raised $86M in 2023
Portfolio highlights
- RoboK — A Cambridge University spin-out building cost-effective 3D sensing software technology
- Tenzo — Tenzo is a restaurant analytics and AI forecasting platform for restaurants, pubs and cafes. Tenzo makes running restaurants easy with full data visibility.
- Riverlane — Riverlane's mission is to make quantum computing useful far sooner than previously imaginable, starting an era of human progress as significant as the industrial and digital revolutions.
Inaki Berenguer is the President and Co-founder at iPronics Programmable Photonics.
Show more...Investment focus
- Industry: E-Commerce, FinTech, Enterprise Software
- Stage:Seed, Angel, Pre-Seed
- Geography: Spain, United States, United Kingdom
Investor stats
- Total investments: 17
- Round size: Seed $215k–$9M; Angel $236k–$500k
- Lead/follow: 12% lead, 88% follow
Portfolio highlights
- Paack — Find the ideal delivery solution to integrate to your e-commerce. We adapt to your retail, offering your customer an amazing delivery experience.
- Libera Bio — Libera Bio is a biopharmaceutical company devoted to the development of a new class of therapeutics to address unmet medical needs in cancer
- Mable (Neurolytic Healthcare) — Neurolytic Healthcare provides personalized medicine for neurological conditions. Neurolytic Healthcare collects and extracts insights from a combination of genetic and biomarker data to enhance diagnosis and help clinicians decide on optimal treatment strategies for neurological conditions.The company delivers digitally and genomically-drivenmedical devices to improve the current treatment of migraine and other neurological disorders, including a diagnostic support tool, pharmacogenetic test, and a mobile app for migraine event prediction.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!We invest in early & growth stage technology companies. We were founded with a mission to support visionaries in building impactful & enduring businesses.
Show more...Investment focus
- Industry: Software, FinTech, Artificial Intelligence
- Stage:Series A, Series B, Series C
- Geography: United States, India, Brazil
Investor stats
- Total investments: 113
- Round size: Series A $12M–$32M; Series B $25M–$102M; Series C $55M–$300M
- Lead/follow: 59% lead, 41% follow
- Last fund: May invest from a new fund soon — raised $1.4B in 2020
Portfolio highlights
- Render — Render is a unified cloud to build and run all your apps and websites with free TLS certificates, global CDN, private networks and auto deploys from Git.
- Flash — Flash is a mobile application and financial service company that facilitates digital payments to businesses.
- Primer — At Primer, we help organizations make the best use of their investment in data, by using best-in-class machine learning and natural language processing technologies.
David Brandes - Managing Director & Co-Founder @ Peace of Meat
Show more...Investment focus
- Industry: Wellness, Life Science, Biotechnology
- Stage:Seed
- Geography: Spain
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Libre Foods — Libre Foods is a biotech startup on a mission to liberate the food system and create a more free future for people, the planet, and animals. The company was founded in 2020 and is based in Barcelona, Catalonia, Spain.
Venture Capital for Entrepreneurs with seasoned experts and advisors to succed in creating value in a meaningful way. Coaching and Mentoring Ideas People
Show more...Investment focus
- Industry: Biotechnology, Robotics, Biopharma
- Stage:Pre-Seed
- Geography: Spain
Investor stats
- Total investments: 3
- Round size: Pre-Seed $134k–$375k
- Lead/follow: 100% lead, 0% follow
Portfolio highlights
- EOXSense — EOXSense aims to transform healthcare by combining biochemical data into digital systems.
- Inrobics — Inrobics proposes rehabilitation model using artificial intelligence and social robots.
- NIMBLE Diagnostics — NIMBLE Diagnostics is a technological organization that develops and provides services related to biotechnology research activities.
Fides Capital is an investment firm, specialized in seed and early stage technology-based companies with scalable B2B business models that have already achieved recurring income. We back committed and experienced teams who are capable of leading ambitious projects with international projection. But, beyond the professional abilities, for usit's essential to have a personal understanding and alignment of interests with the entrepeneurs in order to row together in the same direction. Partnering with the teams is a key pillar in Fides's investment strategy since we like to collaborate actively with them, sharing our experience and knowledge. We invest between 50,000 € and 400,000 € per deal by disbursing funds in gradual installments and we co-invest with other participants that assume the role of lead investor.Our portfolio companies are mainly in the telecom, B2B services, health, fintech and edutech sectors: - AdmInMe (www.admin-me.com) - Agile Content (www.agilecontent.com) - eGarante: (www.egarante.com) - Excom (www.excom.es) - Imegen (www.imegen.es) - Indexa Capital (www.indexacapital.com) - Joinup (www.joinuptaxi.com) - Kuaderno (www.kuaderno.com) - Masmovil (www.masmovil.es) - Next (www.gruponext.es) - Nuubo (www.nuubo.com) - Playfilm (www.playfilm.tv) - Quantyca (www.quantyca.com)
Show more...Investment focus
- Industry: Telecommunications, Software, Automotive
- Stage:Seed, Pre-Seed, Series A
- Geography: Spain
Investor stats
- Total investments: 19
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Devengo — Light-speed transfers. Our Instant Payments API enables seamless integration to automate payouts to your customers in Europe and the UK.
- Atrys Health — ATRYS is an innovative biomedical company dedicated to the provision of specialized diagnostic services and advanced medical treatments. ATRYS combines precision diagnostic techniques in pathological and molecular anatomy, and online diagnostic imaging, with new treatments for radiation oncology. It has offices in Barcelona, Granada and Madrid.
- Energy Solar Tech — Energy Solar Tech is a solar energy technology company.
Being at the forefront of technology takes courage, perseverance, knowledge and experts guiding you to lead the change. Our services Financial & transaction advisory Details Consulting Details Public Funding Details Inveniam numbers since 2020 180 Clients 64 Active Projects 30 Energy andTechnical Audits 42 Strategic and Innovation Consulting Projects 31% Success Rate in Horizon Europe
Show more...Investment focus
- Industry: Biopharma, Health Care, Life Science
- Stage:Seed
- Geography: Spain
Investor stats
- Total investments: 2
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- AtG Therapeutics — At AtG, we develop new drugs and biomarkers to stop cancer metabolic adaptation.
- NIMBLE Diagnostics — NIMBLE Diagnostics is a technological organization that develops and provides services related to biotechnology research activities.
ICREA is a foundation supported by the Catalan Government for the advancement of research.
Show more...Investment focus
- Industry: Life Science, Biotechnology
- Stage:Seed
- Geography: Spain
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- OneChain Immunotherapeutics — CAR-T Immunotherapies against hematological malignancies
I am a food scientist, entrepreneur and investor. Through SFV (sustainablefoodventures.com), I back founders building the future of cell-based, plant-based and recombinant food.
Show more...Investment focus
- Industry: Seafood, Wellness, Life Science
- Stage:Pre-Seed
- Geography: Spain, Iceland
Investor stats
- Total investments: 3
- Round size: Pre-Seed $300k–$500k
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Loki Foods — We're producing sustainable, plant-based foods from the Arctic. Iceland’s first plant-based cod and seafood!
- Sobo Foods — Sobo Foods is a plant based comfort food provider.
- Libre Foods — Libre Foods is a biotech startup on a mission to liberate the food system and create a more free future for people, the planet, and animals. The company was founded in 2020 and is based in Barcelona, Catalonia, Spain.
Fund+ is a venture capital firm that invests in companies operating in the diagnostics, therapeutics, medical devices, and life science sectors. The firm wants to create sustainable shareholders' value, contribute to the development of a leadership position in the life sciences sector, and generate a tangible, beneficial societal impact.Fund+ was established in 2015 and is based in Leuven, Belgium.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Therapeutics
- Stage:Series A, Series B, Series C
- Geography: Belgium, United States, Spain
Investor stats
- Total investments: 25
- Round size: Series A $9.6M–$45M; Series B $20M–$125M
- Lead/follow: 36% lead, 64% follow
Portfolio highlights
- eTheRNA immunotherapies — eTheRNA immunotherapies is developing first in class mRNA immunotherapies for the treatment of cancer and infectious diseases.
- AstriVax — AstriVax aims for initial clinical validation of the platform technology, to develop a broad vaccination pipeline.
- Novadip Biosciences — Novadip Biosciences, an advanced biopharmaceutical company focused on new generation of therapies from adipose stem cells adapted to hard and soft tissues reconstruction.
Arnaldo Marziali
Show more...Investment focus
- Industry: Big Data, Software, Life Science
- Stage:Pre-Seed
- Geography: Spain
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Seqera Labs — Seqera Labs is a Barcelona-based business creating solutions for high-performance computing workloads across cloud and clusters. It was founded by the creators of the popular open-source workflow software Nextflow (http://www.nextflow.io).
Debiopharm invests in Smart Data & Digital Health companies developing technologies that are applicable in the areas of oncology or infectious diseases
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical Device
- Stage:Series A, Series B, Series C
- Geography: Switzerland, United States, France
Investor stats
- Total investments: 23
- Round size: Series A $3.4M–$25M; Series C $15M–$18M
- Lead/follow: 52% lead, 48% follow
Portfolio highlights
- Iktos — Iktos is the only company to offer generative modeling with built-in synthetic accessibility for successful drug discovery
- Yonalink — EHR-to-EDC Data Streaming Bridging the Gap Between Patient Care and Clinical Research LEADER IN INTEROPERABILITY Yonalink provides the missing link in clinical trials with technology that is purpose-built to stream and map up-to-date data, securely automating the transfer of patient data from EHRs to EDCs. Our SaaS solution is bringing new levels of speed, quality, and
- Altis Labs — Altis Labs is the computational imaging company advancing precision medicine. We believe that medical imaging is the richest source of untapped information. Life sciences companies use our software platform, Nota, to accelerate all stages of clinical development. Trained on over 140 million longitudinal real-world images with associated clinicalinformation, our deep learning models predict clinically meaningful outcomes to quantify treatment effect more accurately.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!CDTi (NASDAQ: CDTI) is a cleantech emissions control company that designs, develops and manufactures sustainable solutions to reduce emissions of on- and off-road engine applications.
Show more...Investment focus
- Industry: Software, Information Technology, Health Care
- Stage:Seed, Debt Financing
- Geography: Spain, United States, Mexico
Investor stats
- Total investments: 33
- Round size: Seed $279k–$2.6M; Debt Financing $268k–$461k
- Lead/follow: 9% lead, 91% follow
Portfolio highlights
- Oncovision — Oncovision (GEM Imaging S.A.) is a Spanish technologic start-up company created in 2003 with the initiative of the Corpuscular Physics Institute (CSIC) and the University of Valencia.They work in Molecular Vision applied to Health Sciences focusing in: cancer diagnosis and treatment, and advanced research in neurology, oncology, and cardiology.They are a company focused on Molecular Vision, which creates, develops and markets new medical technologies, global innovations with relevant clinical and economic advantages, often representing a breakthrough in current standards of diagnosis and treatment.ONCOVISION´s original, fresh technology, strong intellectual property, top-level clinical evidence, leading global reference centers, and pioneering protocols, is supported by its dynamic cross-functional team. ONCOVISION is opening unprecedented options in the treatment of cancer and serious cardiac and neurological diseases.Their team and the company’s technologies have been recognized by Spanish and European prestigious institutions. In 2007, the company was selected as one of the “20 Best Technologic Companies in Spain” and won the “National Medical Physics 2007 Congress Award” In 2008, it was one of the “20 Best Health Technology Companies in Europe” by the prestigious European Technology Tour, as well as finalist in the “National 25th Aniversary Enisa Award” Prof. Jose María Benlloch, active member of the company, won in 2008, the well-known “Jaime I” award. Scientists, technicians, and technologists of ONCOVISION have dozens of publications and presentations at scientific and medical conferences worldwide.Their shareholding, based in Valencia, was strengthened in August 2006 by the Spanish venture capital firm Bullnet, unifying its proven track in technological and management capabilities with companies in Spain and Portugal. The company is managed by a multi-task professional team with international experience.With proven clinical and scientific results, differentiated technology with enormous potential for future technological and financial capacity, intellectual property and developing lines, ONCOVISION is today ahead in the Spanish and European Health Industry.
- Atlas Molecular Pharma — Latest News Your browser does not support the video tag.
- Cella Medical Solutions — Cella Medical Solutions allows surgeons to analyze and simulate complex surgery using the latest technologies, dramatically improving results.
Banc Sabadell and the Institut Català de Finances (ICF)
Show more...Investment focus
- Industry: Wellness, Health Care, Medical Device
- Stage:Pre-Seed, Series A, Debt Financing
- Geography: Spain
Investor stats
- Total investments: 3
- Lead/follow: no public data
Portfolio highlights
- Cafler — Your car's personal assistant. Ask for a Cafler now, we move your car for you!
- Amelia Virtual Care — Amelia, formerly Psious VR, is a Virtual Reality software for use by mental health professionals in their therapy sessions with over 100 available virtual environments.
- Adan Medical Innovation — Adan Medical is a digital health company that develops integrated solutions for the management of anaphylaxis. Their mission is to improve the quality of life of patients that suffer severe allergic reactions requiring epinephrine.The company has developed integrated digital solutions to improve the management of anaphylaxis, having nowadays twodifferent products in its pipeline: AnAPPhylaxis, a smart case for epinephrine auto-injectors connected to a mobile App, and WE SAVE, a smart box of epinephrine auto-injectors for public spaces.
Arturo Elizondo is CEO of Clara Foods, a sustainable ingredients company making the world’s most comprehensive egg white substitute. Clara leverages advances in fermentation technology to bring an egg white to the table that is completely animal-free, far more sustainable, and free of salmonella without compromising the qualities we know and love.Prior to joining Clara Foods, Arturo worked at the investment bank Credit Suisse, U.S. Department of Agriculture, and under Supreme Court Justice Sonia Sotomayor.
Show more...Investment focus
- Industry: Wellness, Life Science, Biotechnology
- Stage:Seed, Pre-Seed
- Geography: Spain, Switzerland
Investor stats
- Total investments: 2
- Lead/follow: no public data
Portfolio highlights
- Libre Foods — Libre Foods is a biotech startup on a mission to liberate the food system and create a more free future for people, the planet, and animals. The company was founded in 2020 and is based in Barcelona, Catalonia, Spain.
- Cultivated Biosciences — Cultivated - Creamy, dairy-free indulgence
Sofinnova Partners is a leading European venture capital firm in life sciences, specializing in healthcare and sustainability. Based in Paris, London and Milan, the firm brings together a team of professionals from all over the world with strong scientific, medical and business expertise.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series A, Series B, Series C
- Geography: France, United States, United Kingdom
Investor stats
- Total investments: 232
- Round size: Series A $4.4M–$53M; Series B $7M–$57M; Series C $10M–$54M
- Lead/follow: 47% lead, 53% follow
- Last fund: Likely still investing — fund raised in 2023
Portfolio highlights
- Crescendo Biologics — Crescendo Biologics is a new Cambridge-based company whose vision is to deliver next-generation antibody therapeutics based on novel class-leading platforms.The focus of the company is on developing platforms that will address key issues in generating high-affinity, soluble, human VH antibody fragments. These are the smallest fragments thatretain antibody binding, and have many desirable properties as potential therapeutics. Crescendo will then utilise these platforms for product development of in-house targets or in partnership with other companies.
- Sitryx Therapeutics — Sitryx is a biopharmaceutical company focused on regulating cell metabolism to develop first-in-class disease modifying therapeutics in immuno-oncology and immuno-inflammation. The company was co-founded by a team of world-leading scientists from the United States and Europe who have contributed significantly to the field of immunometabolism.Sitryx was founded in 2018 with seed funding from SV Health Investors and raised $30 million Series A funding from an international syndicate of specialist investors including SV Health Investors, Sofinnova Partners, Longwood Fund and GSK. The company has a pipeline of projects at multiple stages of drug discovery. Sitryx is headquartered in Oxford, UK.
- Tenpoint Therapeutics — Tenpoint Therapeutics is a biotechnology company pursuing vision-restoring engineered cell-based therapeutics.
Ezten Venture Capital Fund
Show more...Investment focus
- Industry: Software, Automotive, Clean Energy
- Stage:Seed
- Geography: Spain
Investor stats
- Total investments: 3
- Lead/follow: no public data
Portfolio highlights
- EPowerlabs — EPowerlabs offers electric mobility components both in passenger car and heavy duty segments to help OEM and Tier 1 build electric cars
- Multiverse Computing — World leaders in quantum computing for the financial industry. The first quantum & quantum-inspired toolbox for finance.
- Atlas Molecular Pharma — Latest News Your browser does not support the video tag.
The strength of the life science industry here and the quality of its technologies. We anticipate that internationally competitive Canadian companies will do well having a fund of this size and calibre at their doorstep, and we believe such a fund will energize the sector and be a magnet for further capital."
Show more...Investment focus
- Industry: Biotechnology, Health Care, Therapeutics
- Stage:Series A, Series C, Series B
- Geography: United States, Canada, Spain
Investor stats
- Total investments: 11
- Lead/follow: no public data
Portfolio highlights
- ARTMS — Expand your reach and astronomically increase your cyclotron production of large volumes of critical isotopes that are essential to the future of patient care.
- EyeYon — EyeYon Medical is an Israeli start-up company that develops innovative medical devices for the treatment of corneal edema.EyeYon Medical was founded by Dr. Daphna Ofer, a senior ophthalmologist, Dr. Arie Marcovich, a senior cornea surgeon, and Nahum Ferera, an experienced business executive. The company operates within the Van Leer TechnologyIncubator.
- Variantyx — Based on clinical whole genome sequencing (WGS) and using a single patient sample, Variantyx's Genomic Unity® test identifies and reports all major variant types including small sequence changes, structural variants, mitochondrial variants and short tandem repeat expansions. This comprehensive test test eliminates the need for traditionalstep-wise, reiterative genetic testing.
International research Institute that pursues to study and eradicate Leukaemia, Lymphoma and other Hemopathies.
Show more...Investment focus
- Industry: Life Science, Biotechnology
- Stage:Seed
- Geography: Spain
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- OneChain Immunotherapeutics — CAR-T Immunotherapies against hematological malignancies
ALANTRA is a PROJECT, a firm being built by all its partners and professionals, a collective aspiration which aims to become an enduring institution for the generations to come. It is a GLOBAL FIRM, being founded by the partners of the 19 countries we are present in.It is an open firm, articulated around the principles of ENTREPRENEURSHIP,PARTNERSHIP, INNOVATION and FLEXIBILITY.Their segment is the MID-MARKET, a space for growth, for new ambitions, for creative and innovative spirits. We grow with our clients, we share their mindset and we build very long-term relationships with them.
Show more...Investment focus
- Industry: Financial Services, Manufacturing, Information Technology
- Stage:Private Equity, Debt Financing, Series B
- Geography: Spain, France, Sweden
Investor stats
- Total investments: 27
- Round size: Debt Financing $7.5M–$39M
- Lead/follow: 44% lead, 56% follow
- Last fund: Likely still investing — fund raised in 2021
Portfolio highlights
- enmacc — The enmacc OTC platform is a energy trading platform for the future of the global energy markets. We are building a next-generation trading platform, powered digital RFQ technology, that will help you to trade smarter, faster and better.
- SunRoof — Roof of the future
- Eturnity AG — Die Eturnity Software automatisiert den und erleichtert den Beratungs- und Verkaufsprozess im Bereich der Erneuerbaren Energiesysteme.
We back bold and purpose-driven founders.
Show more...Investment focus
- Industry: Software, InsurTech, Insurance
- Stage:Series A, Seed
- Geography: Spain, United States, United Kingdom
Investor stats
- Total investments: 96
- Round size: Seed $1M–$6.7M; Series A $1.9M–$30M
- Lead/follow: 46% lead, 54% follow
- Last fund: Likely still investing — fund raised in 2022
Portfolio highlights
- Life5 — The modern life insurance that fits you. Easy, flexible and affordable. The protection you need for your family 100% online
- Raincoat — Get the policy that offers you cash after the hurricane, without deductibles or having to make claims!
- REVER — REVER is born to disrupt how eCommerce returns work by making them easier and faster for everyone.
Grupo Ferrer International is a privately-held European R&D-based pharmaceutical company headquartered in Barcelona. It is active in the pharmaceutical, health, fine chemicals and food sectors in Europe, Latin America, Africa, the Middle East, Asia and the United States. In total, Ferrer's human health care products are commercialized inmore than 95 countries, through 24 international affiliates (including joint ventures) and 70 partners and distributors. Ferrer carries out activities throughout the full pharmaceutical value chain, from R&D to international marketing, including the fine chemical development and the manufacturing of both raw materials and finished pharmaceuticals. Its research centers in Spain and Germany, and manufacturing sites in Europe and Latin America cover the pharmaceutical, diagnostics, vaccine, fine chemical, food and feed sectors.
Show more...Investment focus
- Industry: Biotechnology, Wellness, Biopharma
- Stage:Series A
- Geography: Spain
Investor stats
- Total investments: 2
- Lead/follow: 50% lead, 50% follow
Portfolio highlights
- Venter Pharma SL — Venter Pharma is a biotech company that aims to develop products in the field of gastroenterology to help patients and professionals.It arises on the bases of some research work carried out by PhD. Juan José Aragón Reyes and Alfonso Fernández Mayoralas in the Autonomous University of Madrid and Spanish National Research Council respectively.Venter Pharma focuses on the study of solutions for digestive pathologies, with especial attention to high population prevalence disorders such as lactose intolerance or inflammatory illnesses. Venter Pharma develops innovative products to make a clinical diagnosis easier, simpler and more effective. LacTEST®, is a new diagnosic drug for the diagnosis of lactose intolerance based on a new active substance: Gaxilose
- ABAC Therapeutics — ABAC Therapeutics is aimed at seeking first-in-class drugs for precision treatment of MDR Gram-negative infections. While potent pathogen-specific antibacterial activity is essential, we believe that it is necessary to incorporate early other pharmaceutical properties, such as suitable pharmacokinetics and toxicological characteristics, to maximizethe chance of success in clinical development.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Dr. Milad Alucozai is an Afghan-American neuroscientist, entrepreneur, biotech executive, and global investor with nearly two decades of experience in deep tech, primarily in life sciences. He pushes the boundaries of bioengineering and computational advancements, integrating machine learning and artificial intelligence into biology and medicine.With a strong commitment to commercializing transformative technologies and fostering startup ecosystems worldwide, he is a thought leader and formal mentor for entrepreneurs through organizations like Creative Destruction Lab and the Wyss Institute at Harvard Medical School.Currently, Milad is the head of Bio and Deep Tech at BoxOne Ventures, where he spearheads the firm’s investments in early-stage companies with breakthrough scientific ideas. With nearly 80 early-stage investments, they are recognized as one of North America’s most active venture firms. He is also a Venture Partner at Entrepreneur First, a global fund that has built over 500 companies from scratch with an enterprise value of $10bn. He supports founders with strategy, scaling, business development, securing growth capital, and leadership training, often being their first investor and guiding them from startup inception to IPOs or acquisitions.He started his career in translational neuroscience and multiphysics laboratories before transitioning into founding roles at biotech startups. He is part of the founding team at Mekonos, a San Francisco-based company creating a proprietary cell-engineering platform to support the future of cell and gene therapies. He was also part of the founding team at Corstem, which specialized in machine learning and artificial intelligence software and was later acquired by Circle Cardiovascular, a platform in over 1000 hospitals and more than 40 countries. At Accenture, Milad directed teams of data scientists, designers, and engineers in developing artificial intelligence platforms for global pharmaceutical companies and hospital networks.Milad serves as a Fellow in Healthcare Engineering at the Regenstrief Center. In 2020, he served as an External Advisor to AstraZeneca. He was recognized as a National Science Foundation Scholar and Macklin Fellow at Johns Hopkins Medicine. He graduated Phi Beta Kappa with a degree in Neuroscience from Purdue University’s Honors Program. As a George J. Mitchell Scholar, he completed his master’s in Immunology and earned his doctorate from the Richard M. Fairbanks School of Public Health.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Seed, Series A, Pre-Seed
- Geography: United States, Canada, United Kingdom
Investor stats
- Total investments: 47
- Round size: Seed $91k–$4.5M; Pre-Seed $107k–$1.4M; Series A $25M–$60M
- Lead/follow: 9% lead, 91% follow
Portfolio highlights
- Arpeggio Bio — Arpeggio Biosciences leverages state of the art sequencing approaches coupled with powerful machine learning to uncover novel insights into a compound's biological mechanism of action.The company is diverse set of molecular biologists, computer scientists, and biotechnology enthusiasts passionate about understanding where, why, and howtherapeutics work.
- Future Fields — Future Fields Cellular Agriculture: Serum-Free Growth Media Supplements and Recombinant Proteins - Optimized for the Future of Food.
- Eigen Therapeutics — Eigen Therapeutics is a biotechnology company developing combination therapeutics for cancer. The company is in the research and development of synergistic therapies that improve efficacy while reducing the toxicity of small molecule therapies and immunotherapies, enabling physicians to get access to novel drugs in areas of unmet medical needs.
Innova-Tech Consulting provides independent specialist Audio Visual and Technology consulting services.
Show more...Investment focus
- Industry: Solar, Energy, Medical
- Stage:Series A, Seed, Series B
- Geography: Canada, Spain
Investor stats
- Total investments: 5
- Round size: Series A $1.8M–$16M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- SiXtron Advanced Materials — I found a great domain name for sale on Dan.com. Check it out!
- Libera Bio — Libera Bio is a biopharmaceutical company devoted to the development of a new class of therapeutics to address unmet medical needs in cancer
- Optosecurity — PAX CHECKPOINT combines automated screening lanes with a screening software to create a fully integrated checkpoint solution.
Clave Mayor is a management company of closed investment entities based in Navarra.
Show more...Investment focus
- Industry: Software, Biotechnology, Medical
- Stage:Seed, Series A
- Geography: Spain, Germany, United States
Investor stats
- Total investments: 29
- Round size: Seed $256k–$4.4M; Series A $2.1M–$8.9M
- Lead/follow: 21% lead, 79% follow
Portfolio highlights
- Jeff — Jeff is a company created in 2015 by Eloi Gómez, Adrián Lorenzo and Rubén Muñoz, three Spanish entrepreneurs. It started as a home laundry and dry-cleaning app, but is currently in an expansion process in which, in addition to laundry service, different day-to-day services are added such as hairdressing and beauty, fitness and massages, becomingthe first international omnichannel ecosystem of day-to-day services. It is available to anyone who wants to invest or undertake the necessary solutions to launch their own business under the business lines of the Jeff brand.
- Ojer Pharma — Ojer Pharma engages in the research, development, production, and marketing of dermopharmaceutical products in Spain. It develops prescription medicines, cosmetics, and medical devices. The company has developed a vehiculization technology in the form of bioadhesive transparent gels, which acts as a sustained-release matrix of dermatologicalactives, such as lipophilics and hydrophilics.
- Predictheon — Predictive monitoring for clinicians. Real-time predictions about patient health status to personalize medical care, adjust and individualize therapy, and improve safety.
CRB Inverbio is a private venture capital management firm specialized in life sciences investing in innovative early stage start- ups in biotech, med tech, digital health and medical technologies
Show more...Investment focus
- Industry: Medical, Health Care, Biotechnology
- Stage:Series A, Seed
- Geography: Spain, Mexico
Investor stats
- Total investments: 12
- Round size: Series A $2.1M–$8.9M
- Lead/follow: 33% lead, 67% follow
- Last fund: May invest from a new fund soon — last raise in 2010
Portfolio highlights
- Nuubo — Nuubo is a Spanish medical device company that develops wireless, wearable technologies to monitor physiological parameters. To do so, Nuubo has a platform known as nECG DYNAMIC PLATFORM, which makes it easier to perform and read an electrocardiogram remotely. Specifically, the system patented by Nuubo is made up of three elements: a biomedicalgarment that allows the electrocardiogram signal to be captured without interfering with the patient’s daily activity; a device that continuously records the information captured by the garment and which also allows the data to be sent wirelessly and in real time for processing; and analysis and visualization software that, using artificial intelligence algorithms, can interpret all of the information transmitted by the wireless device.The devices designed by Nuubo allow patients’ hearts to be monitored for longer periods of time and without feeling uncomfortable or intrusive. The company is headquartered in Madrid, Spain.
- Biocross — Biocross, S.L., a biotechnology company, develops blood tests for the diagnosis of Alzheimer’s diseases to neurologists.
- Aglaris Ltd — Aglaris is developing an automated cell culture bioreactor for the mass production of human stem cells.Aglaris produces equipment to ensure cell and tissue culture is an easy, problem-free task. By automating and controlling the cell culture processes, we can obtain cells and tissues with sufficient quality to revitalize regenerative medicine andcell therapies. The technology used by our equipment is unique and is protected by international patents.
We deploy early stage capital to fuel the growth of need-driven health technology companies.
Show more...Investment focus
- Industry: Health Care, Artificial Intelligence, Medical
- Stage:Seed, Pre-Seed, Series A
- Geography: United States, United Kingdom, Austria
Investor stats
- Total investments: 58
- Round size: Seed $1.2M–$6M; Pre-Seed $573k–$964k; Series A $5M–$21M
- Lead/follow: 39% lead, 61% follow
- Last fund: Likely still investing — fund raised in 2022
Portfolio highlights
- basys.ai — Basys.ai automates the process of prior authorization and utilization management to improve costs and timeliness for health plans/payers using an AI-based platform. The proprietary platform automates the process of encoding/digitizing the payer policies using machine learning, thus reducing the piloting timeline by up to 9 months.
- Lillian Care — Lillian is building a nationwide network of health facilities in Germany.
- ALFIE — AI software platform that provides consistent and automated measurements from radiographic images used to assess spinal disorders.
stemar capital private equity philippe costeletos
Show more...Investment focus
- Industry: Genetics, Life Science, Biotechnology
- Stage:Series A
- Geography: Spain
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Veritas Intercontinental — Our test based on whole exome and genome sequencing provides the interpretation of extensive genetic information that can be further analyzed in the future.
You can find here all the institution, its legal framework, as well as the economic and administrative reports and data
Show more...Investment focus
- Industry: Biopharma, Health Care, Life Science
- Stage:Seed
- Geography: Spain
Investor stats
- Total investments: 1
- Lead/follow: 100% lead, 0% follow
Portfolio highlights
- RheoDx — We provide a new way to measure the behavior of blood in motion. RHEO Dx can detect, with a sample of blood as small as a drop, minimum changes in rheological properties, that are an indicator of abnormalities in red blood cells morphology or rigidity. These abnormalities are associated with an enormous set of diseases and conditions, such as bloodcoagulation disorders , malignant homeopathies, malaria, hereditary anaemias, and any other disease related to blood cells rheology.
Kurma Partners is a management company based in Paris, specializing in the financing of innovation in healthcare and biotechnology, from pre-creation to development capital. Kurma Partners, which manages the Kurma Biofund I, II funds and the Kurma Diagnostics fund, is one of the main players in the financing of therapeutic and medical innovationsin Europe, particularly through links with many institutes. research and prestigious hospitals.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical
- Stage:Series A, Seed, Series B
- Geography: France, Spain, Switzerland
Investor stats
- Total investments: 95
- Round size: Seed $2.1M–$7.5M; Series A $2.1M–$50M; Series B $4.1M–$80M
- Lead/follow: 53% lead, 47% follow
- Last fund: May invest from a new fund soon — raised $89M in 2020
Portfolio highlights
- Xeltis — Xeltis is pioneering a restorative approach in cardiovascular therapy.
- Axithra — Saving lives and improving health economics through significant advancement of therapeutic drug monitoring (TDM).
- Kiro — Kiro is an IT company that offers artificial intelligence, ergonomic design, and software development solutions for medical biology.
Pontifax is a healthcare-dedicated venture capital firm.The fund focuses on innovative bio-pharma opportunities.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Therapeutics
- Stage:Series A, Series B, Series C
- Geography: United States, Israel, France
Investor stats
- Total investments: 93
- Round size: Series A $3.8M–$72M; Series B $16M–$100M; Series C $12M–$75M
- Lead/follow: 23% lead, 77% follow
- Last fund: May invest from a new fund soon — last raise in 2020
Portfolio highlights
- Abcuro — Precision Targeting of Highly Cytotoxic T Cells in Autoimmune Disease.
- Precirix — Developing radio-immunotherapeutic drugs for cancer patients.
- ARMGO,Pharma,Inc. — ARMGO Pharma, Inc., a biopharmaceutical company, develops small-molecule therapeutics to treat debilitating cardiac, skeletal muscular, and neurological disorders. It offers rycals, which are calcium release channel stabilizers that act on ryanodine receptor/calcium release channel, a therapeutic target located on thesarcoplasmic/endoplasmic reticulum of the cell for treating chronic heart failure, cardiac arrythmias, and muscle disorders, as well as cognitive disorders, malignant hyperthermia, diabetes, chronic obstructive pulmonary disease, high blood pressure, and bladder dysfunction. The company was incorporated in 2004 and is based in Tarrytown, New York with an additional office in New York, New York.
Arman Anatürk is Co-Founder @ FoodHack.
Show more...Investment focus
- Industry: Biotechnology, Food and Beverage, Wellness
- Stage:Seed, Pre-Seed
- Geography: Spain, Israel, Germany
Investor stats
- Total investments: 5
- Round size: Seed $1.9M–$8.4M
- Lead/follow: 20% lead, 80% follow
Portfolio highlights
- Bosque Foods — Kinoko Labs develops the next generation of meat substitutes, starting with whole-cut meat items made from fungal mycelium produced organically. Headquartered in New York.
- Libre Foods — Libre Foods is a biotech startup on a mission to liberate the food system and create a more free future for people, the planet, and animals. The company was founded in 2020 and is based in Barcelona, Catalonia, Spain.
- Kynda — Keen 4 Greens offers a wide range of vegan products. Founded in 2019, Keen 4 Greens is based in Hamburg, Germany.
Life Science Investor funding in Spain at a glance
Stats across 71 deals from 85 investors.
Access all 85 investors in Spain Life Science startups.
Open ListFAQ
Is Shizune data fresh/accurate?
Shizune has monitored hundreds of funding sources since 2020.
Our investor database is updated every day, so investor data is always fresh.
All metrics are calculated from confirmed public rounds, so the data is accurate.
Can I download investor list?
To download the Life Science Investors in Spain investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.
You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.
Can I access investor database?
To access all 85 investors investing in Spain Life Science startups and 48,091+ more investors, create a Shizune account.
Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.
The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.
You can enrich with email and download the data.
Does Shizune have investor emails and contacts?
Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.
To guarantee the highest discovery rate, we search across 20+ contact search tools.
To maximize delivery rate and reduce bounce rate, we validate emails.
You can enrich your investor list with Shizune. Download it too.
What is Shizune?
Shizune is a 48,091 investor database updated daily.
With Shizune you can:
- browse the database
- use smart matching
- enrich with emails
- download
All you need to find investors for your startup.
Who is Shizune for?
Shizune is built for startup founders by startup founders.
If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.
Is Shizune free?
Shizune is free forever. You can search and browse investors for free.
Email search and export are paid features.
For full info, visit our pricing.
Who built Shizune?
Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.
Contact 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!